PROSTATE CANCER (ADENOCARCINOMA)
Clinical trials for PROSTATE CANCER (ADENOCARCINOMA) explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER (ADENOCARCINOMA) trials appear
Sign up with your email to follow new studies for PROSTATE CANCER (ADENOCARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can surgery tame widespread prostate cancer after drugs?
Disease control Not yet recruitingThis study is for men with advanced prostate cancer that has spread to other parts of the body. It tests whether adding surgery or radiation to the prostate, after 6 months of successful hormone-blocking drug therapy, helps control the cancer longer than continuing with drugs alo…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Apr 02, 2026 00:57 UTC
-
Early trial aims to zap advanced prostate cancer with targeted radiation and chemo
Disease control Not yet recruitingThis early-stage study is testing the safety of combining a standard chemotherapy drug (docetaxel) with a newer targeted radiation drug (Lutetium-PSMA) for men with advanced prostate cancer that has spread and is no longer controlled by hormone therapy. The main goal is to find t…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE1 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug tested to stop prostate Cancer's return after surgery
Disease control Not yet recruitingThis study is testing if a new drug called Rezvilutamide, when added to standard hormone therapy, can help keep prostate cancer from coming back after surgery. It will involve about 33 men with high-risk prostate cancer who have had their prostate removed. The main goal is to see…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug combo tested to control advanced prostate cancer
Disease control Not yet recruitingThis early-stage study is testing whether adding an experimental oral drug called LC-K76 to standard hormone therapy helps control metastatic prostate cancer that still responds to hormones. It will involve about 40 men who have not had prior cancer treatment, focusing primarily …
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Major trial aims to find best radiation combo for prostate cancer
Disease control Not yet recruitingThis study is for men with prostate cancer that hasn't spread. It will compare four different radiation treatment plans to see which one best controls the cancer while causing the fewest side effects. All participants will get a modern, precise type of radiation, but some will ge…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE2, PHASE3 • Sponsor: Affidea Nu-med Center of Oncological DIagnostics and Therapy • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Needle heat or freeze tested to zap spreading prostate cancer
Disease control Not yet recruitingThis study is testing a minimally invasive procedure called thermal ablation for men whose prostate cancer has spread to a few other spots in the body. Doctors use a needle to apply extreme heat or cold directly to the tumors to destroy them. The goal is to see if this is a safe …
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New program aims to keep cancer patients connected to primary care during treatment
Disease control Not yet recruitingThis study tests whether a new care coordination program helps cancer patients better manage chronic conditions like high blood pressure, diabetes, and high cholesterol during cancer treatment. Researchers will compare patients who receive the new program to those getting usual c…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Glowing dye could help surgeons spot prostate cancer
Diagnosis Not yet recruitingThis early study is testing a new fluorescent dye called AS1986NS. It is designed to make prostate cancer cells glow under special light during a biopsy, potentially helping surgeons see the cancer more clearly. The main goal is to check if the dye is safe when given in a very sm…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Phase: PHASE1, PHASE2 • Sponsor: Antelope Surgical Solutions, Inc • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC
-
Tracking the hidden cost of prostate cancer care
Symptom relief Not yet recruitingThis study aims to understand how a standard combination treatment for prostate cancer—targeted radiation plus hormone-blocking therapy—affects men's sexual function. It will follow 130 men with a specific intermediate-risk prostate cancer, tracking changes in erectile function a…
Matched conditions: PROSTATE CANCER (ADENOCARCINOMA)
Sponsor: CancerCare Manitoba • Aim: Symptom relief
Last updated Mar 19, 2026 14:56 UTC